Should Molecular Subtype Influence the Interpretation of Serial 68 Ga-HER2 PET/CT During Neoadjuvant Therapy?
TO THE EDITOR: I read with great interest the prospective study by Gao et al. demonstrating that serial 68Ga-HER2 PET/CT performed after 2 cycles of neoadjuvant therapy and before surgery predicts pathologic complete response (pCR) in human epidermal growth factor receptor 2 (HER2)–positive
Authors
- Kadri Altundağ (ORCID: https://orcid.org/0000-0003-3357-0096)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2026-10-29
- DOI
- https://doi.org/10.2967/jnumed.126.273659
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00